Patterns of treatment failure for PD-(L)1 refractory extensive-stage small cell lung cancer in continued PD-(L)1 treatment

BACKGROUND: Although immunotherapy greatly extends overall survival (OS) of patients with extensive-stage small cell lung cancer (ES-SCLC), a number of patients develop immunotherapy resistance (IR). Patterns of failure in ES-SCLC are not clarified. Our study aims to explore the clinical pattern of...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Li, Liu, Tong, Wang, Xingwen, Wang, Jianbo, Wang, Jun, Yuan, Meng, Yang, Yunxin, Zhang, Yingying, Wang, Hang, Hu, Pingping, Zhang, Jiandong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Neoplasia Press 2023
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10206491/
https://www.ncbi.nlm.nih.gov/pubmed/37182510
http://dx.doi.org/10.1016/j.tranon.2023.101687

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10206491/
https://www.ncbi.nlm.nih.gov/pubmed/37182510
http://dx.doi.org/10.1016/j.tranon.2023.101687

Ejemplares similares